Loading…
Gem Aromatics (GEMAROMA)₹142.19+2.43%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Gem Aromatics reported sales of ₹99.14 Cr, up 12.7% from Jun 2025, and net profit of −₹7.86 Cr, down 198.4% year on year. For the year to Mar 2026, sales were ₹367 Cr and net profit ₹0.99 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 93.01 | 113 | 97.23 | 203 | 87.98 | 89.89 | 79.21 | 111 | 99.14 |
| Expenses | 78.61 | 96.96 | 83.89 | 156 | 72.87 | 86.59 | 71.96 | 94.84 | 95.68 |
| Operating Profit | 14.22 | 15.37 | 13.05 | 45.94 | 14.88 | 3.06 | 7.03 | 15.72 | 3.31 |
| OPM % | 15.3% | 13.6% | 13.5% | 22.7% | 16.9% | 3.4% | 8.9% | 14.2% | 3.3% |
| Other Income | 0.88 | 0.72 | 0.49 | −0.42 | 1.26 | 0.97 | −1.65 | 0.29 | 0.15 |
| Interest | 1.09 | 1.32 | 2.21 | 3.43 | 3.51 | 3.49 | 2.57 | 2.96 | 2.87 |
| Depreciation | 1.68 | 1.83 | 1.88 | 1.91 | 1.81 | 3.04 | 8.69 | 8.99 | 9.11 |
| Profit before tax | 12.32 | 12.93 | 9.43 | 40.15 | 10.81 | −2.53 | −5.94 | 4.04 | −8.56 |
| Tax % | 30.3% | 24.7% | 20.9% | 31.2% | 26.0% | 2.4% | −15.8% | 75.0% | −7.8% |
| Net Profit | 8.58 | 9.73 | 7.47 | 27.58 | 7.99 | −2.57 | −5.00 | 1.00 | −7.86 |
| EPS (Rs) | 1.84 | 2.09 | 1.60 | 5.91 | 1.71 | −0.50 | −0.97 | 0.20 | −1.52 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 307 | 315 | 427 | 454 | 506 | 367 | 379 |
| Expenses | 275 | 265 | 359 | 374 | 415 | 326 | 349 |
| Operating Profit | 31.03 | 49.02 | 66.08 | 78.09 | 88.14 | 41.03 | 29.12 |
| OPM % | 10.0% | 16.0% | 16.0% | 17.0% | 18.0% | 11.0% | 7.7% |
| Other Income | 3.99 | 2.99 | 0.00 | 1.99 | 0.99 | 0.99 | −0.24 |
| Interest | 1.99 | 2.99 | 5.99 | 5.99 | 7.98 | 12.96 | 11.89 |
| Depreciation | 2.99 | 3.99 | 4.99 | 5.99 | 6.99 | 22.95 | 29.83 |
| Profit before tax | 30.05 | 44.02 | 56.10 | 68.06 | 74.13 | 6.01 | −12.99 |
| Tax % | 23.0% | 30.0% | 20.0% | 26.0% | 28.0% | 78.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Profit | 23.01 | 31.01 | 44.96 | 50.03 | 52.96 | 0.99 | −14.43 |
| EPS (Rs) | 130.35 | 175.20 | 251.15 | 10.73 | 11.43 | 0.28 | −2.79 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 2.01 | 2.01 | 2.01 | 9.01 | 8.98 | 10.01 |
| Reserves | 108 | 136 | 178 | 221 | 275 | 440 |
| Borrowings | 54.82 | 77.73 | 89.64 | 112 | 226 | 152 |
| Other Liabilities | 19.90 | 23.00 | 25.88 | 26.01 | 25.88 | 40.07 |
| Total Liabilities | 186 | 240 | 296 | 369 | 535 | 642 |
| Fixed Assets | 24.08 | 36.11 | 36.14 | 50.14 | 54.18 | 254 |
| CWIP | 1.99 | 0.99 | 10.95 | 29.88 | 125 | 5.97 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 160 | 203 | 249 | 289 | 355 | 381 |
| Inventories | 82.05 | 134 | 143 | 174 | 166 | 234 |
| Trade receivables | 53.17 | 40.13 | 80.27 | 45.13 | 142 | 77.28 |
| Cash & equivalents | 7.99 | 5.99 | 10.99 | 15.98 | 3.99 | 15.99 |
| Total Assets | 186 | 240 | 296 | 369 | 535 | 642 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 0.00 | −5.02 | 15.05 | 40.13 | −25.06 | 30.09 |
| Cash from investing activity | −5.01 | −15.02 | −18.02 | −50.01 | −92.12 | −102 |
| Cash from financing activity | 6.99 | 17.99 | 5.99 | 14.99 | 105 | 77.96 |
| Net cash flow | 1.99 | −1.99 | 3.99 | 4.99 | −12.99 | 4.99 |
| Capex | 4.99 | 13.98 | 13.99 | 38.99 | 105 | 94.96 |
| Free cash flow | −5.98 | −18.95 | 0.99 | 0.99 | −130 | −64.81 |
| CFO / OP % | 23.9% | 11.9% | 50.0% | 70.9% | 0.0% | 99.9% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 62 | 45 | 67 | 36 | 101 | 75 |
| Inventory days | 120 | 206 | 164 | 187 | 160 | 309 |
| Days payable | 22 | 26 | 23 | 19 | 15 | 24 |
| Cash conversion cycle | 159 | 224 | 207 | 202 | 245 | 359 |
| Working capital days | 90 | 110 | 102 | 121 | 115 | 179 |
| ROCE % | — | 25.0% | 25.0% | 24.0% | 19.0% | 3.0% |
For the Jun 2026 quarter, Gem Aromatics reported sales of ₹99.14 Cr, up 12.7% year on year and net profit of −₹7.86 Cr, down 198.4% year on year. The operating margin was 3.3%.
Gem Aromatics' sales for the year to Mar 2026 were ₹367 Cr; over the last twelve months they were ₹379 Cr.
Net profit for the year to Mar 2026 was ₹0.99 Cr, and −₹14.43 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−2.79.
Gem Aromatics reported borrowings of ₹152 Cr at Mar 2026, against cash and equivalents of ₹15.99 Cr.
Cash from operations was ₹30.09 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹64.81 Cr.